BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Vir Biotechnology Inc. 9/3/19 $150 Ph II Immunotech Biopharm Ltd. (HKEX) 9/2/19 TBD Ph II TiumBio Co. Ltd....
BioCentury | Apr 22, 2019
Distillery Therapeutics

TGFBR1 inhibition for GATA4-deficient lung cancer

...testing for liver cancer and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
BioCentury | Jan 17, 2019
Company News

TiumBio grants Chiesi rights to develop TGF-β molecules to treat respiratory diseases

...million comprising an upfront payment and development, regulatory and commercial milestones, plus single digit royalties. TiumBio Co. Ltd....
BioCentury | Aug 23, 2018
Distillery Therapeutics

Hepatic

...testing for liver cancer and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
BioCentury | Jul 17, 2018
Distillery Therapeutics

Endocrine/Metabolic

...I/II testing for HCC and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
Items per page:
1 - 5 of 5
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Vir Biotechnology Inc. 9/3/19 $150 Ph II Immunotech Biopharm Ltd. (HKEX) 9/2/19 TBD Ph II TiumBio Co. Ltd....
BioCentury | Apr 22, 2019
Distillery Therapeutics

TGFBR1 inhibition for GATA4-deficient lung cancer

...testing for liver cancer and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
BioCentury | Jan 17, 2019
Company News

TiumBio grants Chiesi rights to develop TGF-β molecules to treat respiratory diseases

...million comprising an upfront payment and development, regulatory and commercial milestones, plus single digit royalties. TiumBio Co. Ltd....
BioCentury | Aug 23, 2018
Distillery Therapeutics

Hepatic

...testing for liver cancer and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
BioCentury | Jul 17, 2018
Distillery Therapeutics

Endocrine/Metabolic

...I/II testing for HCC and myelodysplastic syndrome (MDS) and Phase I testing for solid tumors. TiumBio Co. Ltd....
Items per page:
1 - 5 of 5